A detailed history of Geode Capital Management, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 5,431,911 shares of RXRX stock, worth $39.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,431,911
Previous 4,775,908 13.74%
Holding current value
$39.8 Million
Previous $35.8 Million 0.06%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$5.92 - $8.6 $3.88 Million - $5.64 Million
656,003 Added 13.74%
5,431,911 $35.8 Million
Q2 2024

Aug 09, 2024

BUY
$7.35 - $10.05 $9.74 Million - $13.3 Million
1,324,743 Added 38.39%
4,775,908 $35.8 Million
Q1 2024

May 13, 2024

BUY
$9.13 - $15.52 $1.14 Million - $1.94 Million
125,180 Added 3.76%
3,451,165 $34.4 Million
Q4 2023

Feb 13, 2024

BUY
$5.09 - $10.79 $953,331 - $2.02 Million
187,295 Added 5.97%
3,325,985 $32.8 Million
Q3 2023

Nov 13, 2023

BUY
$6.59 - $15.86 $2.17 Million - $5.23 Million
329,547 Added 11.73%
3,138,690 $24 Million
Q2 2023

Aug 11, 2023

BUY
$4.56 - $9.94 $299,405 - $652,650
65,659 Added 2.39%
2,809,143 $21 Million
Q1 2023

May 15, 2023

BUY
$6.42 - $9.64 $857,301 - $1.29 Million
133,536 Added 5.12%
2,743,484 $18.3 Million
Q4 2022

Feb 13, 2023

BUY
$7.16 - $12.7 $1.99 Million - $3.53 Million
277,865 Added 11.91%
2,609,948 $20.1 Million
Q3 2022

Nov 14, 2022

BUY
$7.83 - $13.6 $6.47 Million - $11.2 Million
826,087 Added 54.85%
2,332,083 $24.8 Million
Q2 2022

Aug 12, 2022

BUY
$5.04 - $9.26 $1.07 Million - $1.97 Million
212,240 Added 16.4%
1,505,996 $12.3 Million
Q1 2022

May 13, 2022

SELL
$6.16 - $18.03 $7,398 - $21,654
-1,201 Reduced 0.09%
1,293,756 $9.26 Million
Q4 2021

Feb 11, 2022

BUY
$16.14 - $21.86 $11.8 Million - $16 Million
732,626 Added 130.28%
1,294,957 $22.2 Million
Q3 2021

Nov 12, 2021

BUY
$19.03 - $41.33 $1.24 Million - $2.7 Million
65,382 Added 13.16%
562,331 $12.9 Million
Q2 2021

Aug 13, 2021

BUY
$18.0 - $37.42 $8.95 Million - $18.6 Million
496,949 New
496,949 $18.1 Million

Others Institutions Holding RXRX

About RECURSION PHARMACEUTICALS, INC.


  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.32B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.